Array BioPharma competitorsClear all

Array BioPharma's top competitors include Recro Pharma, BTG, Clinigen Group and Durect.
Array BioPharma
Array BioPharma
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
Recro Pharma
Recro Pharma
Recro Pharma is a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post operative pain.
BTG
BTG
BTG is an international specialist healthcare company.
Clinigen Group
Clinigen Group
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
Durect
Durect
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
Founding Date
Founding Date
1998
Founding Date
2006
Founding Date
1948
Founding Date
2010
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Boulder, US HQ
Miami, US
Boston, US
Phoenix, US
New York, US
Chicago, US
Houston, US
see more
Locations
Malvern, US HQ
Locations
London, GB HQ
Rosedale, AU
Ottawa, CA
Düsseldorf, DE
Hong Kong , HK
Ataşehir, TR
Ffostrasol, GB
see more
Locations
Burton upon Trent, GB HQ
Warriewood, AU
Chuo City, JP
Auckland, NZ
Singapore, SG
Pretoria, ZA
Weybridge, GB
see more
Locations
Cupertino, US HQ
Employees
Employees
29843% increase
Employees
255
Employees
N/A
Employees
465200% increase
Employees
885% decrease
Valuation ($)
Valuation ($)
6.5 b
Valuation ($)
201.4 m
Valuation ($)
N/A
Valuation ($)
1.8 b
Valuation ($)
86.6 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.1 k
Twitter followers
1.3 k
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
416225
Alexa Website Rank
194878
Alexa Website Rank
1054241
Alexa Website Rank
260657
Alexa Website Rank
138208

Financial

Revenue (est.)
Revenue (est.)
$173.8m (FY, 2018)
Revenue (est.)
$77.3m (FY, 2018)
Revenue (est.)
£731.3m (FY, 2019)
Revenue (est.)
£339.6m (FY, 2018)
Revenue (est.)
$18.6m (FY, 2018)
Cost of goods
Cost of goods
N/A
Cost of goods
$43.2m (FY, 2018)
Cost of goods
£221m (FY, 2019)
Cost of goods
£216.1m (FY, 2018)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$34.2m (FY, 2018)
Gross profit
£510.3m (FY, 2019)
Gross profit
£123.6m (FY, 2018)
Gross profit
N/A
Net income
Net income
($147.3m) (FY, 2018)
Net income
($79.7m) (FY, 2018)
Net income
£88.3m (FY, 2019)
Net income
£24.4m (FY, 2018)
Net income
($25.3m) (FY, 2018)
For sources of this data, please see the company profile

View company profiles

Recro Pharma
HQ
Malvern, US
Employees
255

Recro Pharma is a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post operative pain.

View company
BTG
HQ
London, GB

BTG is an international specialist healthcare company.

View company
Clinigen Group
HQ
Burton upon Trent, GB
Employees
465

A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time

View company
Durect
HQ
Cupertino, US
Employees
88↓ 5% decrease

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.

View company